<VariationArchive VariationID="280414" VariationName="NM_001278716.2(FBXL4):c.618_621dup (p.Glu208fs)" VariationType="Duplication" Accession="VCV000280414" Version="3" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2016-12-06" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="264218" VariationID="280414">
      <GeneList>
        <Gene Symbol="FBXL4" FullName="F-box and leucine rich repeat protein 4" GeneID="26235" HGNC_ID="HGNC:13601" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q16.1-16.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="98868535" stop="98947946" display_start="98868535" display_stop="98947946" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="99321600" stop="99395848" display_start="99321600" display_stop="99395848" Strand="-" />
          </Location>
          <OMIM>605654</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001278716.2(FBXL4):c.618_621dup (p.Glu208fs)</Name>
      <CanonicalSPDI>NC_000006.12:98917610:CAGTC:CAGTCAGTC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6q16.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="98917610" stop="98917611" display_start="98917610" display_stop="98917611" variantLength="4" positionVCF="98917610" referenceAlleleVCF="C" alternateAlleleVCF="CCAGT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="99365486" stop="99365487" display_start="99365486" display_stop="99365487" variantLength="4" positionVCF="99365486" referenceAlleleVCF="C" alternateAlleleVCF="CCAGT" />
      </Location>
      <ProteinChange>E208fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.99365488_99365491dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.99365488_99365491dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.98917612_98917615dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.98917612_98917615dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033903.1" sequenceAccession="NG_033903" sequenceVersion="1" change="g.35393_35396dup">
            <Expression>NG_033903.1:g.35393_35396dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278716.2" sequenceAccession="NM_001278716" sequenceVersion="2" change="c.618_621dup" MANESelect="true">
            <Expression>NM_001278716.2:c.618_621dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001265645.1" sequenceAccession="NP_001265645" sequenceVersion="1" change="p.Glu208fs">
            <Expression>NP_001265645.1:p.Glu208fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012160.5" sequenceAccession="NM_012160" sequenceVersion="5" change="c.618_621dup">
            <Expression>NM_012160.5:c.618_621dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_036292.2" sequenceAccession="NP_036292" sequenceVersion="2" change="p.Glu208fs">
            <Expression>NP_036292.2:p.Glu208fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10602946" DB="ClinGen" />
        <XRef Type="rs" ID="886041625" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001278716.2(FBXL4):c.618_621dup (p.Glu208fs) AND not provided" Accession="RCV000298072" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-06-03" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001278716.2(FBXL4):c.618_621dup (p.Glu208fs) AND Mitochondrial DNA depletion syndrome 13" Accession="RCV000502064" Version="2">
        <ClassifiedConditionList TraitSetID="12015">
          <ClassifiedCondition DB="MedGen" ID="C3809592">Mitochondrial DNA depletion syndrome 13</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-08-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-03" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2016-12-06" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23993193</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23993194</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25868664</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28940506</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32445240</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12015" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18313" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mitochondrial DNA depletion syndrome 13</ElementValue>
                <XRef ID="MONDO:0014198" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MTDPS13</ElementValue>
                <XRef Type="MIM" ID="615471" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13298" />
                <XRef ID="13298" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">FBXL4-related encephalomyopathic mitochondrial DNA (mtDNA) depletion syndrome is a multi-system disorder characterized primarily by congenital or early-onset lactic acidosis and growth failure, feeding difficulty, hypotonia, and developmental delay. Other neurologic manifestations can include seizures, movement disorders, ataxia, autonomic dysfunction, and stroke-like episodes. All affected individuals alive at the time they were reported (median age: 3.5 years) demonstrated significant developmental delay. Other findings can involve the heart (hypertrophic cardiomyopathy, congenital heart malformations, arrhythmias), liver (mildly elevated transaminases), eyes (cataract, strabismus, nystagmus, optic atrophy), hearing (sensorineural hearing loss), and bone marrow (neutropenia, lymphopenia). Survival varies; the median age of reported deaths was two years (range 2 days – 75 months), although surviving individuals as old as 36 years have been reported. To date FBXL4-related mtDNA depletion syndrome has been reported in 50 individuals.</Attribute>
                <XRef ID="NBK425540" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28383868</ID>
                <ID Source="BookShelf">NBK425540</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29517884</ID>
                <ID Source="BookShelf">NBK487393</ID>
              </Citation>
              <XRef ID="369897" DB="Orphanet" />
              <XRef ID="C3809592" DB="MedGen" />
              <XRef ID="MONDO:0014198" DB="MONDO" />
              <XRef Type="MIM" ID="615471" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="643675" SubmissionDate="2019-01-29" DateLastUpdated="2019-04-17" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="GDX:942426|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000330325" DateUpdated="2019-04-17" DateCreated="2016-12-06" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-12-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.618_621dupACTG pathogenic variant in the FBXL4 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.618_621dupACTG variant causes a frameshift starting with codon Glutamic acid 208, changes this amino acid to a Threonine residue, and creates a premature Stop codon at position 5 of the new reading frame, denoted p.Glu208ThrfsX5. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.618_621dupACTG variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.618_621dupACTG as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FBXL4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="6" alternateAllele="CAGTCAGT" referenceAllele="CAGT" start="99365486" stop="99365487" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012160.3:c.618_621dupACTG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1154689" SubmissionDate="2017-08-14" DateLastUpdated="2017-08-28" DateCreated="2017-08-28">
        <ClinVarSubmissionID localKey="NM_012160.4:c.618_621dup|OMIM:615471" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000598192" DateUpdated="2017-08-28" DateCreated="2017-08-28" Type="SCV" Version="1" SubmitterName="Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine" OrgID="506302" OrganizationCategory="laboratory" OrgAbbreviation="WongLab-BCM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-08-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The NM_012160.4:c.618_621dup (NP_036292.2:p.Glu208ThrfsTer5) [GRCH38: NC_000006.12:g.98917612_98917615dup] variant in FBXL4 gene is interpretated to be a Pathogenic based on ACMG guidelines (PMID: 25741868). This variant meets one or more of the following evidence codes reported in the ACMG-guideline. PVS1:This variant is a predcted null variant in FBXL4 where loss of function is a known mechanism of disease. PM2:This variant is absent in key population databases. PP4:Patientâ€™s phenotype or family history is highly specific for FBXL4. PP5:Reputable source(s) suggest that the variant is pathogenic. Based on this evidence code ClinGen Pathogenicity Calculator (PMID:28081714) suggested that the variant is Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012160.4:c.618_621dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615471" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2956232</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7979549" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4863883|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004294641" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28940506</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32445240</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23993193</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23993194</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25868664</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 280414). This premature translational stop signal has been observed in individual(s) with clinical features of FBXL4-related conditions (PMID: 28940506, 32445240). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu208Thrfs*5) in the FBXL4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FBXL4 are known to be pathogenic (PMID: 23993193, 23993194, 25868664).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FBXL4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.99365486_99365487insCAGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="643675" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7979549" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1154689" TraitType="Disease" MappingType="XRef" MappingValue="615471" MappingRef="OMIM">
        <MedGen CUI="C3809592" Name="Mitochondrial DNA depletion syndrome 13" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

